Webinar on the KIK-AS Clinical Trials of GTX-102
placeholder

Additional details on the clinical trials for GTX-102 are available at the link below:

https://clinicaltrials.gov/ct2/show/NCT04259281 – A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome (KIK-AS)

Share
Facebook
Twitter
LinkedIn
Email
Foundation Updates
Rare Disease Week: Washington, DC Round-up
Rare Disease Week: Washington, DC Round-up
International Angelman Day 2023 Global News Roundup
International Angelman Day 2023 Global News Roundup
Research Updates
Learn more about the ORCA measure
Learn more about the ORCA measure
FAST attends the American Society of Gene & Cell Therapy’s annual scientific meeting
FAST attends the American Society of Gene & Cell Therapy’s annual scientific meeting